Theriva Biologics, Inc.
Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in …
Biotechnology
US, Rockville [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Theriva Biologics, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDTheriva Biologics, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Theriva Biologics, Inc..
If you want to see a demo, head over to the financial segments of AAPL